12:00 AM
Feb 19, 2007
 |  BC Week In Review  |  Company News  |  Deals

Adeza, Cytyc deal

CYTC agreed to acquire women’s health company ADZA for $452 million, or $24 per share, in cash. The price is a 55% premium to ADZA’s close of $15.53 on Feb. 9, the last trading day before the deal was announced. The deal will give CYTC

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >